Knowledge base

Contact
FAQ
Privacy

Companies
Sophia Genetics
Portfolio

Sophia Genetics

Verified

Helps clinicians and physicians predict genetic diseases better

Launch date

2011

Employees

501-1000 people

Ownership

public, angel, venture capital

Market cap

$169m

Net debt

-

Firm valuation

$1.1b (Public information from Jul 2021)

Share price

$2.64 SOPH

Saint-Sulpice Canton of Vaud (HQ)

http://sophiagenetics.com

https://twitter.com/sophiagenetics https://www.linkedin.com/company/sophiagenetics/

Deals in current and previous year:

10X Genomics
Interactive Biosoftware

B2B
saas
health
enterprise software
biotechnology
deep learning
big data
deep tech
machine learning
nanotech
artificial intelligence

biotechnology
analytics
data analytics
spinout
genetics
dna
verified unicorns and $1b exits
genome engineering
knowledge management
insurtech related
tech for hospitals & clinics
techscale200
medical imaging
clinical decision support

All Current Exits Rounds Co-Investors

Dealroom signal

Name

Market

Type

Location

Last Round

Status